NPI: 1053838789 · CHARLOTTE, NC 28269 · Pediatrics Physician · NPI assigned 08/24/2017
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 08/24/2017 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 334 | $11K |
| 2019 | 4,225 | $157K |
| 2020 | 8,216 | $282K |
| 2021 | 21,707 | $553K |
| 2022 | 33,097 | $807K |
| 2023 | 34,579 | $633K |
| 2024 | 22,955 | $62K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,035 | 5,732 | $441K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4,316 | 3,540 | $409K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,836 | 3,234 | $362K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7,615 | 6,417 | $346K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3,060 | 2,601 | $309K |
| 99199 | Unlisted special service, procedure or report | 55,764 | 53,975 | $185K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,372 | 1,082 | $71K |
| D0145 | Oral evaluation for a patient under three years of age | 1,838 | 1,552 | $68K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 6,043 | 5,098 | $59K |
| 99051 | 2,201 | 1,823 | $53K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 369 | 326 | $36K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 523 | 417 | $32K |
| D1206 | Topical application of fluoride varnish | 1,838 | 1,552 | $30K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,532 | 1,233 | $26K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 776 | 656 | $22K |
| 96161 | 2,497 | 2,094 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 455 | 437 | $9K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 75 | 67 | $8K |
| 90461 | 4,760 | 3,991 | $8K | |
| 96127 | 1,253 | 1,047 | $6K | |
| 99381 | 43 | 29 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 119 | 117 | $4K |
| 87634 | 88 | 80 | $2K | |
| 87807 | 90 | 60 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 78 | 38 | $1K |
| 92552 | 1,910 | 1,622 | $870.95 | |
| 99177 | 2,867 | 2,435 | $529.34 | |
| 85018 | 764 | 637 | $378.17 | |
| 88720 | 57 | 40 | $363.38 | |
| 90686 | 759 | 703 | $282.47 | |
| 99173 | 1,593 | 1,322 | $154.64 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 13 | 12 | $141.30 |
| 90674 | 327 | 271 | $77.51 | |
| 36416 | 769 | 605 | $54.74 | |
| 83655 | 122 | 119 | $15.68 | |
| 90710 | 222 | 186 | $0.00 | |
| 90648 | 875 | 699 | $0.00 | |
| 90670 | 3,104 | 2,620 | $0.00 | |
| 90633 | 244 | 210 | $0.00 | |
| 90700 | 19 | 14 | $0.00 | |
| 90698 | 1,427 | 1,227 | $0.00 | |
| 90680 | 1,526 | 1,278 | $0.00 | |
| 90744 | 386 | 350 | $0.00 | |
| 90723 | 537 | 427 | $0.00 | |
| 99000 | 16 | 15 | $0.00 |